BiaDerm - Bioelectronics for Advanced Directed Epithelial Repair and Monitoring
| Reference number | |
| Coordinator | Chalmers Tekniska Högskola AB - Chalmers Tekniska Högskola Inst f Mikroteknologi & nanovetensk |
| Funding from Vinnova | SEK 436 000 |
| Project duration | April 2025 - September 2025 |
| Status | Completed |
| Venture | Global cooperation 2025 |
| Call | Planning grant for international proposal 2025 |
Important results from the project
The project met its objective to build a strong European consortium, validate key technological components and prepare a competitive EIC Transition-förslag for 2025. The new proposal fully addresses the shortcomings identified in the previous evaluation and includes a clear strategy for regulatory, clinical and commercial aspects. Additional results include the formation of Bioelectrix Sweden AB which is now part of the Chalmers Ventures portfolio.
Expected long term effects
The project has created the foundation for bringing a new generation of bioelectronic wound dressings to the market, combining active healing with real-time monitoring. In the long term, this work will strengthen Sweden’s role in the European health tech sector, contribute to reduced healthcare costs and better treatment outcomes for patients with chronic wounds, and support the growth of a new deep-tech company with global potential.
Approach and implementation
The project was structured around three main activities: (i) consolidating the consortium and work packages, (ii) setting up preclinical validation with MedPharm, and (iii) rewriting the EIC Transition proposal together with professional consultants. The project followed the timeline closely and resulted in a mature and well-coordinated European application ready for submission to EIC Transition 2025.